Dr. John Gerald Galvez Canto, MD

Dr. Canto practices at Watson Clinic in Lakeland, Florida.

Dr. Canto's NPI, 1336112747, was assigned on February 8, 2006. Dr. Canto graduated from University Of Minnesota Medical School in 1991. Dr. Canto holds Florida license ME89400.

Dr. Canto's primary practice is Watson Clinic, at 1430 Lakeland Hills Blvd, Lakeland, FL 33805 in Polk County. The practice phone is (863) 680-7700.

Dr. Canto's primary practice is Watson Clinic in Lakeland, Florida. Dr. Canto is also affiliated with Lakeland Regional Health Medical Center. The medical group on file is Watson Clinic. Dmand AI also links Dr. Canto to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Canto practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Canto's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Canto is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Canto's licenses on file in 4 states: Florida, Alabama, Texas and Minnesota.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Canto treats.

CMS data shows 11,429 Medicare services from Dr. Canto across 36 procedure codes in 2024, for 2,767 Medicare patients. Medicare paid $1,322,328 for them.

CMS counts 2,767 Medicare patients who saw Dr. Canto in 2024. The largest group is 75 to 84, with 1,243 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Canto's median patient age at 77, with 49% women.

In 2024, Dr. Canto wrote 8,819 Medicare Part D claims for 1,146 patients. 69% of them were for generic drugs. CMS names the drug for 8,576 of them, across 54 drugs with 11 or more claims each, at $2,924,634 in total drug cost. In 2023, CMS named 8,173 claims across 57 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Canto for performance year 2024, reported through an alternative payment model (APM). Dr. Canto accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Canto in 2009. The most frequent topics are Myocardial Infarction, Hospital Mortality and Thrombolytic Therapy. Dr. Canto has published most often in J Am Coll Cardiol. Dr. Canto's most frequent co-authors are Michael George Shlipak, MD, Brad G. Angeja, MD and Alan S. Go, MD.

CMS Open Payments shows 1,508 general payments to Dr. Canto from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 90% of the total. Amarin Pharma Inc. paid the most, $413,175.

Dmand AI lists 2 awards for Dr. Canto, most recently CMS Stage 1 EHR in 2013.

Dr. Canto graduated from University Of Minnesota Medical School in 1991.

Dr. Canto is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.